Clinical Immunology, Neuropharmacology and Drug Development

Neuropharmacological Interventions in Neurodegenerative Disorders

This track is dedicated to exploring pharmacological strategies for treating neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s disease. Researchers are encouraged to submit abstracts on novel drug candidates, mechanisms of action, and clinical trial results. The track will cover both symptomatic treatments and disease-modifying therapies, with a focus on advancing our understanding of neurodegenerative processes. Attendees will learn about the latest therapeutic approaches that aim to slow or halt the progression of these debilitating diseases.